Research and development

Research and Development: Hongjitang Pharmaceutical focuses on R&D, currently holding over 75 patents, with R&D investment exceeding 5% of sales revenue. The R&D department employs over 80 people, including 7 PhDs and 90% of them hold master’s degrees. We have a 3600m² research institute and a 700m² laboratory equipped with advanced experimental equipment such as HPLC, LC-MS, and ICP-MS. Most of the equipment in our pilot plant is imported from Japan and can be used for extraction, concentration, and formulation processes. The superior experimental conditions and working environment ensure the smooth progress of projects.
GMP-Certified Montmorillonite (Diosmectite) API Manufacturing
-
1
-
2
-
3
-
4
